Shawn mcCormick
CIK 1454092 · Chief Financial Officer · last filed 2026-05-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.31M
Companies
7
Total Filings
65
Lifetime Open-Market Net
-$885.0K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INSP | Director | 30,712 | $42.70 | $1.31M | -$638.9K | 17 | 2026-05-11 |
| NEVRO CORP (NVRO) Delisted | Director | 0 | $5.84 | $0 | -$113.0K | 15 | 2025-04-03 |
| SURMODICS INC (SRDX) Delisted | Director | 9,210 | $42.98 | $395.8K | $0 | 13 | 2020-02-18 |
| ENTELLUS MEDICAL INC (ENTL) Delisted | Director | 0 | — | — | $50.0K | 4 | 2018-03-01 |
| Wright Medical Group N.V. (WMGI.Z) Delisted | Chief Financial Officer | 36,034 | — | — | $0 | 1 | 2015-10-05 |
| Wright Medical Group N.V. (TRNX) Delisted | Chief Financial Officer | 44,506 | — | — | -$117.1K | 10 | 2015-06-05 |
| ev3 Inc. (EVVV) Delisted | Senior VP and CFO | 0 | — | — | -$66.1K | 5 | 2010-07-13 |
Recent Filings · Page 2 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-13 | INSP | Exer (M) | +2,500 | $2.4K | EDGAR |
| 2024-05-06 | INSP | Grant (A) | +716 | $0 | EDGAR |
| 2023-06-09 | NEVRO CORP (NVRO) Delisted | Buy (P) | +7,500 | $171.6K | EDGAR |
| 2023-05-30 | NEVRO CORP (NVRO) Delisted | Grant (A) | +6,754 | $0 | EDGAR |
| 2023-05-01 | INSP | Grant (A) | +669 | $0 | EDGAR |
| 2023-03-21 | INSP | Exer (M) | +4,000 | $3.8K | EDGAR |
| 2022-05-27 | NEVRO CORP (NVRO) Delisted | Grant (A) | +4,155 | $0 | EDGAR |
| 2022-05-27 | NEVRO CORP (NVRO) Delisted | Grant (A) | +4,155 | $0 | EDGAR |
| 2022-05-10 | INSP | Grant (A) | — | $0 | EDGAR |
| 2021-05-26 | NEVRO CORP (NVRO) Delisted | Mixed | +685 | -$72.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.